Innovative Technology SOM Biotech utilizes a proprietary AI-driven drug discovery platform, positioning itself as a cutting-edge innovator in the pharmaceutical sector and offering opportunities for technology collaboration or licensing partnerships.

Strategic Collaborations The company's recent partnerships with academic institutions such as the University of Minnesota and Ewha Womans University highlight an openness to collaborative research and licensing deals, which could be expanded into joint development or co-marketing opportunities.

Focus on Orphan Diseases With a specialization in neurological orphan diseases, SOM Biotech targets niche markets that often require specialized drug development services or supply chain solutions, presenting opportunities for medical suppliers or specialty service providers.

Emerging COVID-19 Portfolio The company's active R&D in COVID-19 drug candidates offers potential for pharmaceutical or biotech partners interested in pandemic response drugs, manufacturing capacity, or distribution channels for early-stage therapeutics.

Growth and Leadership Recent strategic hires and advisory appointments demonstrate a focus on growth and governance, indicating potential for investment, consultancy, or executive-level partnership opportunities to support expansion efforts.